The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Acylcarnitines—old actors auditioning for new roles in metabolic physiology
Open accessAbstract
Perturbations in metabolic pathways can cause substantial increases in plasma and tissue concentrations of long-chain acylcarnitines (LCACs). For example, the levels of LCACs and other acylcarnitines rise in the blood and muscle during exercise, as changes in tissue pools of acyl-coenzyme A reflect accelerated fuel flux that is incompletely coupled to mitochondrial energy demand and capacity of the tricarboxylic acid cycle. This natural ebb and flow of acylcarnitine generation and accumulation contrasts with that of inherited fatty acid oxidation disorders (FAODs), cardiac ischaemia or type 2 diabetes mellitus. These conditions are characterized by very high (FAODs, ischaemia) or modestly increased (type 2 diabetes mellitus) tissue and blood levels of LCACs. Although specific plasma concentrations of LCACs and chain-lengths are widely used as diagnostic markers of FAODs, research into the potential effects of excessive LCAC accumulation or the roles of acylcarnitines as physiological modulators of cell metabolism is lacking. Nevertheless, a growing body of evidence has highlighted possible effects of LCACs on disparate aspects of pathophysiology, such as cardiac ischaemia outcomes, insulin sensitivity and inflammation. This Review, therefore, aims to provide a theoretical framework for the potential consequences of tissue build-up of LCACs among individuals with metabolic disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Myocardial Fatty Acid Metabolism in Health and Disease
Lopaschuk, G. D., Ussher, J. R., Folmes, C. D. L., Jaswal, J. S., & Stanley, W. C. (2010) · Physiological Reviews · doi:10.1152/physrev.00015.2009 · Cited by 2,179
Koves, T. R., Ussher, J. R., Noland, R. C., Slentz, D., Mosedale, M., Ilkayeva, O., Bain, J., Stevens, R., Dyck, J. R. B., Newgard, C. B., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.013 · Cited by 1,990
Itani, S. I., Ruderman, N. B., Schmieder, F., & Boden, G. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2005 · Cited by 1,390
Lee, J. Y., Sohn, K. H., Rhee, S. H., & Hwang, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011695200 · Cited by 1,299
Holland, W. L., Brozinick, J. T., Wang, L.-P., Hawkins, E. D., Sargent, K. M., Liu, Y., Narra, K., Hoehn, K. L., Knotts, T. A., Siesky, A., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.01.002 · Cited by 1,232
Self-citationHuman metabolic individuality in biomedical and pharmaceutical research
CARDIoGRAM, Suhre, K., Shin, S.-Y., Petersen, A.-K., Mohney, R. P., Meredith, D., Wägele, B., Altmaier, E., Deloukas, P., Erdmann, J., et al. (2011) · Nature · doi:10.1038/nature10354 · Cited by 1,017
Hediger, M. A., Romero, M. F., Peng, J.-B., Rolfs, A., Takanaga, H., & Bruford, E. A. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1192-y · Cited by 985
Horvath, S. E., & Daum, G. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.07.002 · Cited by 907
Ceramides in insulin resistance and lipotoxicity
SUMMERS, S. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2005.11.002 · Cited by 848
Screening Newborns for Inborn Errors of Metabolism by Tandem Mass Spectrometry
Wilcken, B., Wiley, V., Hammond, J., & Carpenter, K. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025225 · Cited by 677
Mihalik, S. J., Goodpaster, B. H., Kelley, D. E., Chace, D. H., Vockley, J., Toledo, F. G. S., & DeLany, J. P. (2010) · Obesity · doi:10.1038/oby.2009.510 · Cited by 653
The mitochondrial transporter family SLC25: Identification, properties and physiopathology
Palmieri, F. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.05.005 · Cited by 615
Adams, S. H., Hoppel, C. L., Lok, K. H., Zhao, L., Wong, S. W., Minkler, P. E., Hwang, D. H., Newman, J. W., & Garvey, W. T. (2009) · The Journal of Nutrition · doi:10.3945/jn.108.103754 · Cited by 598
Self-citationSaturated fatty acids activate TLR-mediated proinflammatory signaling pathways
Huang, S., Rutkowsky, J. M., Snodgrass, R. G., Ono-Moore, K. D., Schneider, D. A., Newman, J. W., Adams, S. H., & Hwang, D. H. (2012) · Journal of Lipid Research · doi:10.1194/jlr.d029546 · Cited by 592
Self-citationProtein kinase C, an elusive therapeutic target?
Mochly-Rosen, D., Das, K., & Grimes, K. V. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3871 · Cited by 563
Wong, S. W., Kwon, M.-J., Choi, A. M. K., Kim, H.-P., Nakahira, K., & Hwang, D. H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.044065 · Cited by 562
Carnitine and Acylcarnitines: Pharmacokinetic, Pharmacological and Clinical Aspects
Reuter, S. E., & Evans, A. M. (2012) · Clinical Pharmacokinetics · doi:10.1007/bf03261931 · Cited by 493
Lee, J. Y., Zhao, L., Youn, H. S., Weatherill, A. R., Tapping, R., Feng, L., Lee, W. H., Fitzgerald, K. A., & Hwang, D. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312990200 · Cited by 493
Diacylglycerol-mediated insulin resistance
Erion, D. M., & Shulman, G. I. (2010) · Nature Medicine · doi:10.1038/nm0410-400 · Cited by 489
Fatty Acid Oxidation Disorders
Rinaldo, P., Matern, D., & Bennett, M. J. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.082201.154705 · Cited by 479
Koves, T. R., Li, P., An, J., Akimoto, T., Slentz, D., Ilkayeva, O., Dohm, G. L., Yan, Z., Newgard, C. B., & Muoio, D. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507621200 · Cited by 464
An, J., Muoio, D. M., Shiota, M., Fujimoto, Y., Cline, G. W., Shulman, G. I., Koves, T. R., Stevens, R., Millington, D., & Newgard, C. B. (2004) · Nature Medicine · doi:10.1038/nm995 · Cited by 450
Mammalian mitochondrial β-oxidation
EATON, S., BARTLETT, K. B., & POURFARZAM, M. (1996) · Biochemical Journal · doi:10.1042/bj3200345 · Cited by 422
Muoio, D. M., Noland, R. C., Kovalik, J.-P., Seiler, S. E., Davies, M. N., DeBalsi, K. L., Ilkayeva, O. R., Stevens, R. D., Kheterpal, I., Zhang, J., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.005 · Cited by 372
Analysis and update of the human solute carrier (SLC) gene superfamily
He, L., Vasiliou, K., & Nebert, D. W. (2009) · Human Genomics · doi:10.1186/1479-7364-3-2-195 · Cited by 349
McHugh, D. M. S., Cameron, C. A., Abdenur, J. E., Abdulrahman, M., Adair, O., Al Nuaimi, S. A., Åhlman, H., Allen, J. J., Antonozzi, I., Archer, S., et al. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e31820d5e67 · Cited by 348
Acylcarnitines activate proinflammatory signaling pathways
Rutkowsky, J. M., Knotts, T. A., Ono-Moore, K. D., McCoin, C. S., Huang, S., Schneider, D., Singh, S., Adams, S. H., & Hwang, D. H. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00656.2013 · Cited by 332
Self-citationNoland, R. C., Koves, T. R., Seiler, S. E., Lum, H., Lust, R. M., Ilkayeva, O., Stevens, R. D., Hegardt, F. G., & Muoio, D. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.032888 · Cited by 317
Lopaschuk, G. D., Wall, S. R., Olley, P. M., & Davies, N. J. (1988) · Circulation Research · doi:10.1161/01.res.63.6.1036 · Cited by 284
Acylcarnitines: potential implications for skeletal muscle insulin resistance
Aguer, C., McCoin, C. S., Knotts, T. A., Thrush, A. B., Ono‐Moore, K., McPherson, R., Dent, R., Hwang, D. H., Adams, S. H., & Harper, M. (2015) · The FASEB Journal · doi:10.1096/fj.14-255901 · Cited by 240
Self-citationCarnitine Palmitoyltransferase Deficiencies
Bonnefont, J.-P., Demaugre, F., Prip-Buus, C., Saudubray, J.-M., Brivet, M., Abadi, N., & Thuillier, L. (1999) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1999.2938 · Cited by 229
Acylcarnitine profile analysis
Rinaldo, P., Cowan, T. M., & Matern, D. (2008) · Genetics in Medicine · doi:10.1097/gim.0b013e3181614289 · Cited by 228
Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation.
Corr, P. B., Creer, M. H., Yamada, K. A., Saffitz, J. E., & Sobel, B. E. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113978 · Cited by 206
A Deficiency of Carnitine–Acylcarnitine Translocase in the Inner Mitochondrial Membrane
Stanley, C. A., Hale, D. E., Berry, G. T., Deleeuw, S., Boxer, J., & Bonnefont, J.-P. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207023270104 · Cited by 183
Serum Levels of Acylcarnitines Are Altered in Prediabetic Conditions
Mai, M., Tönjes, A., Kovacs, P., Stumvoll, M., Fiedler, G. M., & Leichtle, A. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082459 · Cited by 178
Formation and Regulation of Mitochondrial Membranes
Schenkel, L. C., & Bakovic, M. (2014) · International Journal of Cell Biology · doi:10.1155/2014/709828 · Cited by 173
Spiekerkoetter, U. (2010) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9090-x · Cited by 170
Adams, R. J., Cohen, D. W., Gupte, S., Johnson, J. D., Wallick, E. T., Wang, T., & Schwartz, A. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86329-9 · Cited by 169
Ha, C. Y., Kim, J. Y., Paik, J. K., Kim, O. Y., Paik, Y., Lee, E. J., & Lee, J. H. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04244.x · Cited by 162
Regulation of the activity of caspases by L ‐carnitine and palmitoylcarnitine
Mutomba, M. C., Yuan, H., Konyavko, M., Adachi, S., Yokoyama, C. B., Esser, V., McGarry, J., BABIOR, B. M., & Gottlieb, R. A. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01817-2 · Cited by 158
Insulin resistance and altered systemic glucose metabolism in mice lacking Nur77
Chao, L. C., Wroblewski, K., Zhang, Z., Pei, L., Vergnes, L., Ilkayeva, O. R., Ding, S. Y., Reue, K., Watt, M. J., Newgard, C. B., et al. (2009) · Diabetes · doi:10.2337/db09-0763 · Cited by 154
Carnitine acyltransferases and their influence on CoA pools in health and disease
RAMSAY, R. (2004) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2004.06.002 · Cited by 153
Sampey, B. P., Freemerman, A. J., Zhang, J., Kuan, P. F., Galanko, J. A., O’Connell, T. M., Ilkayeva, O., Muehlbauer, M. J., Stevens, R. D., Newgard, C. B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038812 · Cited by 145
Relationship between acid-soluble carnitine and coenzyme A pools in vivo
Brass, E. P., & Hoppel, C. L. (1980) · Biochemical Journal · doi:10.1042/bj1900495 · Cited by 141
Inhibition of bovine heart Na+,K+-ATPase by palmitylcarnitine and palmityl-CoA
Wood, J. M., Bush, B., Pitts, B. J. R., & Schwartz, A. (1977) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(77)90356-4 · Cited by 134
Carnitine metabolism in normal-weight and obese human subjects during fasting
Hoppel, C. L., & GENUTH, S. M. (1980) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1980.238.5.e409 · Cited by 111
Application of tandem mass spectrometry to biochemical genetics and newborn screening
Carpenter, K. H., & Wiley, V. C. (2002) · Clinica Chimica Acta · doi:10.1016/s0009-8981(02)00135-3 · Cited by 93
Optimal dietary therapy of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency
Gillingham, M. B., Connor, W. E., Matern, D., Rinaldo, P., Burlingame, T., Meeuws, K., & Harding, C. O. (2003) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(03)00073-8 · Cited by 91
Disorders of mitochondrial long‐chain fatty acid oxidation
Pollitt, R. J. (1995) · Journal of Inherited Metabolic Disease · doi:10.1007/bf00710058 · Cited by 87
Katoh, N., Wrenn, R. W., Wise, B. C., Shoji, M., & Kuo, J. F. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.8.4813 · Cited by 80
Violante, S. N., IJlst, L., Brinke, H. T., de Almeida, I. T., Wanders, R. J. A., Ventura, F. V., & Houten, S. M. (2013) · The FASEB Journal · doi:10.1096/fj.12-216689 · Cited by 75
Long-Chain Acylcarnitine Induces Ca2+ Efflux from the Sarcoplasmic Reticulum
Yamada, K. A., Kanter, E. M., & Newatia, A. (2000) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200007000-00002 · Cited by 74
McCoin, C. S., Knotts, T. A., Ono‐Moore, K. D., Oort, P. J., & Adams, S. H. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00602.2014 · Cited by 71
Self-citationIsackson, P. J., Bennett, M. J., Lichter‐Konecki, U., Willis, M. J. H., Nyhan, W. L., Sutton, V. R., Tein, I., & Vladutiu, G. D. (2008) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2008.05.002 · Cited by 66
Mitochondrial trifunctional protein defects: Clinical implications and therapeutic approaches
Rector, R. S., Payne, R. M., & Ibdah, J. A. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.04.014 · Cited by 58
Lipid‐Induced Metabolic Dysfunction in Skeletal Muscle
Muoio, D. M., & Koves, T. R. (2007) · Novartis Foundation symposium · doi:10.1002/9780470985571.ch4 · Cited by 57
Lamers, J. M. J., Stinis, H. T., Montfoort, A., & Hülsmann, W. C. (1984) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(84)90283-9 · Cited by 54
El-Hayek, R., Valdivia, C. R., Valdivia, H. H., et al. (1993) · Biophysical Journal · doi:10.1016/s0006-3495(93)81101-9 · Cited by 53
Pochini, L., Oppedisano, F., & Indiveri, C. (2004) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2003.12.001 · Cited by 49
Long-Chain Acylcarnitines Regulate the hERG Channel
Ferro, F., Ouillé, A., Tran, T.-A., Fontanaud, P., Bois, P., Babuty, D., Labarthe, F., & Guennec, J. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041686 · Cited by 47
Wu, J., & Corr, P. B. (1995) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1995.268.6.h2405 · Cited by 44
Wolkowicz, P. E., & McMillin-Wood, J. B. (1980) · Biochemical Journal · doi:10.1042/bj1860257 · Cited by 35
Modulation by palmitoylcarnitine of protein kinase C activation.
Nakadate, T., & Blumberg, P. M. (1987) · PubMed · Cited by 35
Requero, M. A., González, M., Goñi, F. M., Alonso, A., & Fidelio, G. D. (1995) · FEBS Letters · doi:10.1016/0014-5793(94)01326-v · Cited by 33
Therapies in inborn errors of oxidative metabolism
Schiff, M., Bénit, P., Jacobs, H. T., Vockley, J., & Rustin, P. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.04.006 · Cited by 23
Activation and Inhibition of Reconstituted Cardiac L-Type Calcium Channels by Palmitoyl-L-carnitine
Liu, Q.-Y., & Rosenberg, R. L. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1649 · Cited by 22
Palmitoyl carnitine: An endogenous promotor of calcium efflux from rat heart mitochondria
Baydoun, A. R., Markham, A., Morgan, R. M., & Sweetman, A. J. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90307-3 · Cited by 21
den Bosch, J. D. V., Hoeks, J., Timmers, S., Houten, S. M., van Dijk, P., Boon, W., van Beurden, D., Schaart, G., Kersten, S., Voshol, P. J., et al. (2010) · Obesity · doi:10.1038/oby.2010.152 · Cited by 20
Mitochondrial Ca2+ fluxes: role of free fatty acids, acyl-CoA and acylcarnitine
Villiers, M. D., & Lochner, A. (1986) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(86)90289-4 · Cited by 19
Palmitoylcarnitine modulates interaction between protein kinase C βII and its receptor RACK1
Sobiesiak‐Mirska, J., & Nałęcz, K. A. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05154.x · Cited by 8
Cited by
Dynamics and functions of lipid droplets
Olzmann, J. A., & Carvalho, P. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0085-z · Cited by 2,740
New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain
Feldman, E. L., Nave, K.-A., Jensen, T. S., & Bennett, D. L. H. (2017) · Neuron · doi:10.1016/j.neuron.2017.02.005 · Cited by 915
Nguyen, T. B., Louie, S. M., Daniele, J. R., Tran, Q., Dillin, A., Zoncu, R., Nomura, D. K., & Olzmann, J. A. (2017) · Developmental Cell · doi:10.1016/j.devcel.2017.06.003 · Cited by 610
Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials
Dambrova, M., Makrecka-Kuka, M., Kuka, J., Vilskersts, R., Nordberg, D., Attwood, M. M., Smesny, S., Sen, Z. D., Guo, A. C., Oler, E., et al. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000408 · Cited by 507
Metabolic network failures in Alzheimer's disease: A biochemical road map
Toledo, J. B., Arnold, M., Kastenmüller, G., Chang, R., Baillie, R. A., Han, X., Thambisetty, M., Tenenbaum, J. D., Suhre, K., Thompson, J. W., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.01.020 · Cited by 468
Metadata
- Authors
- McCoin, C. S., Knotts, T. A., & Adams, S. H.
- Venue
- Nature Reviews Endocrinology
- Published
- 2015-08-25
- Volume
- 11
- Issue
- 10
- Pages
- 617-625
- ISSN
- 1759-5029 (ISSN-L)
- 1759-5037
- OpenAlex
- W2242613625
- Cited by
- 344
- References
- 72
- FWCI
- 2.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.